Chris Yallop

Chris Yallop has a strong background in biopharmaceutical development and operations. Chris has held key positions at companies such as Glaxo Group Research, Novo Nordisk, Crucell, TNO Pharma, Batavia Biopharma, and Batavia Bioservices. Chris'sroles have included overseeing research and development, heading biopharmaceutical development, and serving as a Statutary Director. Chris'scareer spans from 1990 to the present day, showcasing their expertise and leadership in the pharmaceutical industry.

Chris Yallop completed a BSc in Biochemistry and Biotechnology at the University of Liverpool from 1987 to 1990. Chris then pursued a PHD in Discovery and Production of Novel Antibiotics at the same university from 1990 to 1993. Following this, they obtained a Post Doctoral degree in Nutrient transport in industrial microorganisms at UCL from 1993 to 1996.